Skip to main content
. 2020 Apr 21;15:88. doi: 10.1186/s13014-020-01519-1

Fig. 5.

Fig. 5

A 69-years old patient with biochemical recurrence of prostate cancer (pT2c pN0 R0 Gleason score 9, preoperative PSA 11.7 ng/ml) and evidence of PET-positive lymph node metastases (a) and radiotherapy-plan with dose-escalation to the PET-positive lymph nodes (b)